Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
Drug Name | M1774 |
Trade Name | |
Synonyms | M-1774|M 1774|tuvusertib |
Drug Descriptions |
M1774 is an ATR inhibitor, which potentially decreases tumor growth (Cancer Res (2022) 82 (12_Supplement): 2588). |
DrugClasses | ATR Inhibitor 16 |
CAS Registry Number | 674783-97-2 |
NCIT ID | C171067 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Avelumab + M1774 | Avelumab M1774 | 0 | 1 |
Cemiplimab + M1774 | Cemiplimab M1774 | 0 | 1 |
Fulvestrant + M1774 | Fulvestrant M1774 | 0 | 1 |
M1774 | M1774 | 1 | 4 |
M1774 + Peposertib | M1774 Peposertib | 0 | 1 |
M1774 + PLX038 | M1774 PLX038 | 0 | 1 |
M1774 + Temozolomide | M1774 Temozolomide | 0 | 1 |
M1774 + ZEN-3694 | M1774 ZEN-3694 | 0 | 1 |